Lead sponsor
McGill University
5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
5
Trials led
0
Active
122
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Not applicable
3
Trials by status
Completed
4
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial PancreasHbA1c ≤12%not applicableCompleted36
Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 DiabetesHbA1c ≤10%Ph 2Completed28
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 DiabetesHbA1c ≤11%not applicableUnknown26